1. Janigan DT: Cytoplasmic bodies in the adrenal cortex of patients treated with spirolactone. Lancet. 1963, 1: 850-852.
2. Kovacs K, Horvath E, Singer W: Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortex. J Clin Pathol. 1973, 26: 949-957. 10.1136/jcp.26.12.949.
3. Aiba M, Suzuki H, Kageyama K, Murai M, Tazaki H, Abe O, Saruta T: Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa. Am J Pathol. 1981, 103: 404-410.
4. Hsu SM, Raine L, Martin HF: Spironolactone bodies: an immunoperoxidase study with biochemical correlation. Am J Clin Pathol. 1981, 75: 92-95.
5. Vacher-Lavenu MC, Lellouch-Tubiana A, Louvel A, Daudet-Monsac M, Abelanet R: Spironolactone bodies. Light and electron microscope study apropos of 4 cases of adrenal adenomas with primary hyperaldosteronism. Ann Pathol. 1982, 2: 311-319.